Alex Sirois

Alex Sirois

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

Allakos Is a Cautionary Tale of Biopharmaceutical Investing

ALLK stock dropped off a cliff following disappointing study results, which illustrates what can go wrong in risky biopharma equities.

GameStop Shows It Isn’t Immune to Economic Laws

GME stock will eventually suffer the same immutable problems until it is no longer relevant, whether fanatics like it or not.

Ethereum’s Dominance is Under Mounting Scrutiny

The price of Ethereum and its completive position are eroding amid a growing chorus of concerns from crypto watchers.

Bitcoin’s Tailwinds Relate to Increasing Institutional Acceptance

Bitcoin should rebound again and these catalysts suggest $100k is possible as Wall Street furthers its acceptance.

7 OTC Stocks That Made It Big in 2021 for Multiple Reasons

OTC stocks are often difficult to gauge. These seven that made it big in 2021 are no different but remain interesting stories.